{"id":"https://openalex.org/W1978535500","doi":"https://doi.org/10.1007/s12402-011-0070-2","title":"Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials","display_name":"Health-related quality of life in ADHD: a pooled analysis of gender differences in five atomoxetine trials","publication_year":2012,"publication_date":"2012-01-20","ids":{"openalex":"https://openalex.org/W1978535500","doi":"https://doi.org/10.1007/s12402-011-0070-2","mag":"1978535500","pmid":"https://pubmed.ncbi.nlm.nih.gov/22271466"},"language":"en","primary_location":{"id":"doi:10.1007/s12402-011-0070-2","doi":"https://doi.org/10.1007/s12402-011-0070-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12402-011-0070-2","pdf_url":null,"source":{"id":"https://openalex.org/S198724541","display_name":"ADHD Attention Deficit and Hyperactivity Disorders","issn_l":"1866-6116","issn":["1866-6116","1866-6647"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ADHD Attention Deficit and Hyperactivity Disorders","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091487905","display_name":"Peter M. Wehmeier","orcid":"https://orcid.org/0000-0002-0407-2234","observed_orcids":["https://orcid.org/0000-0002-0407-2234"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4210105615","display_name":"Central Institute of Mental Health","ror":"https://ror.org/01hynnt93","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210105615"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Peter M. Wehmeier","raw_affiliation_strings":["Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Post Box 12 21 20, 68072 Mannheim, Germany. peter.wehmeier@vitos-weilmuenster.de","Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Post Box 12 21 20, 68072 Mannheim, Germany. peter.wehmeier@vitos-weilmuenster.de","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210105615"]},{"raw_affiliation_string":"Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210105615"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048043719","display_name":"Alexander Schacht","orcid":"https://orcid.org/0000-0001-9516-6262","observed_orcids":["https://orcid.org/0000-0001-9516-6262"]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexander Schacht","raw_affiliation_strings":["Medical Department, Lilly Deutschland GmbH, Bad Homburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Department, Lilly Deutschland GmbH, Bad Homburg, Germany","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081820165","display_name":"Rodrigo Escobar","orcid":"https://orcid.org/0000-0003-4454-9399","observed_orcids":["https://orcid.org/0000-0003-4454-9399"]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rodrigo Escobar","raw_affiliation_strings":["Neuroscience Products, Medical Science, Lilly Research Laboratories Japan, Sannomiya Plaza Building, 7-1-5 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan","Neuroscience Products, Medical Science, Lilly Research Laboratories Japan, Kobe, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Products, Medical Science, Lilly Research Laboratories Japan, Sannomiya Plaza Building, 7-1-5 Isogami-dori, Chuo-ku, Kobe, 651-0086, Japan","institution_ids":["https://openalex.org/I4210108315"]},{"raw_affiliation_string":"Neuroscience Products, Medical Science, Lilly Research Laboratories Japan, Kobe, Japan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084236833","display_name":"Amaia Hervas G","orcid":"https://orcid.org/0000-0003-0051-5752","observed_orcids":["https://orcid.org/0000-0003-0051-5752"]},"institutions":[{"id":"https://openalex.org/I4210096566","display_name":"University Hospital M\u00fatua de Terrassa","ror":"https://ror.org/011335j04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096566","https://openalex.org/I4210130102"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Amaia Hervas","raw_affiliation_strings":["Child and Adolescent Mental Health Unit, University Hospital Mutua de Terrassa, Terrassa, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Child and Adolescent Mental Health Unit, University Hospital Mutua de Terrassa, Terrassa, Spain","institution_ids":["https://openalex.org/I4210096566"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111748218","display_name":"Ruth A Dickson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210164863","display_name":"Eli Lilly (Canada)","ror":"https://ror.org/05p8kt313","country_code":"CA","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210164863"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Ruth Dickson","raw_affiliation_strings":["Eli Lilly Canada, Toronto, ON, Canada","Eli Lilly Canada, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly Canada, Toronto, ON, Canada","institution_ids":["https://openalex.org/I4210164863"]},{"raw_affiliation_string":"Eli Lilly Canada, Toronto, Canada","institution_ids":["https://openalex.org/I4210164863"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5091487905"],"corresponding_institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4210105615"],"apc_list":{"value":3140,"currency":"USD","value_usd":3140},"apc_paid":null,"fwci":1.3967,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.78551448,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"4","issue":"1","first_page":"25","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10182","display_name":"Child and Adolescent Psychosocial and Emotional Development","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9539999961853027},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gender-differences","display_name":"gender differences","score":0.9900000095367432},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.38499999046325684},{"id":"https://openalex.org/keywords/adolescents","display_name":"adolescents","score":0.9449999928474426},{"id":"https://openalex.org/keywords/adhd-symptoms","display_name":"ADHD symptoms","score":0.6959999799728394},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5899999737739563},{"id":"https://openalex.org/keywords/risk-avoidance","display_name":"risk avoidance","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.978657603263855},{"id":"https://openalex.org/C2909253567","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine hydrochloride","level":5,"score":0.6451849341392517},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.6343528628349304},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5956808924674988},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5937164425849915},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45102399587631226},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.43879061937332153},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.42869535088539124},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36807024478912354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3247586488723755},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.2085108458995819},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18468722701072693},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006304","descriptor_name":"Health Status","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012727","descriptor_name":"Sex Characteristics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s12402-011-0070-2","doi":"https://doi.org/10.1007/s12402-011-0070-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s12402-011-0070-2","pdf_url":null,"source":{"id":"https://openalex.org/S198724541","display_name":"ADHD Attention Deficit and Hyperactivity Disorders","issn_l":"1866-6116","issn":["1866-6116","1866-6647"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-70","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ADHD Attention Deficit and Hyperactivity Disorders","raw_type":"journal-article"},{"id":"pmid:22271466","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22271466","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Attention deficit and hyperactivity disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W629283852","https://openalex.org/W641074116","https://openalex.org/W1578459135","https://openalex.org/W1974753535","https://openalex.org/W1978747908","https://openalex.org/W1980505282","https://openalex.org/W1983302342","https://openalex.org/W1989407607","https://openalex.org/W1989444430","https://openalex.org/W1994279898","https://openalex.org/W2025666345","https://openalex.org/W2026749227","https://openalex.org/W2028909100","https://openalex.org/W2029733708","https://openalex.org/W2034939353","https://openalex.org/W2036048514","https://openalex.org/W2036679985","https://openalex.org/W2042184165","https://openalex.org/W2050458545","https://openalex.org/W2055196953","https://openalex.org/W2062473516","https://openalex.org/W2077805314","https://openalex.org/W2086188333","https://openalex.org/W2090619706","https://openalex.org/W2090672792","https://openalex.org/W2094632207","https://openalex.org/W2098399548","https://openalex.org/W2105411076","https://openalex.org/W2107288488","https://openalex.org/W2123002449","https://openalex.org/W2140773305","https://openalex.org/W2140856358","https://openalex.org/W2143445712","https://openalex.org/W2163740897","https://openalex.org/W2163817145","https://openalex.org/W2168058010","https://openalex.org/W2168895300","https://openalex.org/W2171074660","https://openalex.org/W2406768254","https://openalex.org/W2914686075","https://openalex.org/W3177640887","https://openalex.org/W4241390709"],"related_works":["https://openalex.org/W1989407607","https://openalex.org/W2098399548","https://openalex.org/W2092503547","https://openalex.org/W2014826962","https://openalex.org/W3095018133","https://openalex.org/W1978747908","https://openalex.org/W1996091936","https://openalex.org/W2008455052","https://openalex.org/W7096084970","https://openalex.org/W2055196953"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}